“COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY”. The Research of Medical Science Review, vol. 3, no. 6, June 2025, pp. 94-100, https://www.thermsr.com/index.php/Journal/article/view/1284.